BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
143 results:

  • 1. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
    Fehm T; Cottone F; Dunton K; André F; Krop I; Park YH; De Laurentiis M; Miyoshi Y; Armstrong A; Borrego MR; Yerushalmi R; Duhoux FP; Takano T; Lu W; Egorov A; Kim SB
    Lancet Oncol; 2024 May; 25(5):614-625. PubMed ID: 38697155
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative breast cancer.
    Sato K; Miura K; Tamori S; Akimoto K
    Cancer Genomics Proteomics; 2024; 21(3):316-326. PubMed ID: 38670590
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
    Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
    ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer.
    Gong X; Zheng C; Cai Y; Zhang W; Zhu B; Rong R; Kong Y; Zhang Y; Wang J; Li Y; Zhang P
    J Control Release; 2024 Mar; 367():637-648. PubMed ID: 38295994
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Global research trends and prospects related to tumor microenvironment within Triple Negative breast cancer: a bibliometric analysis.
    Li P; Li J; Tong X; Xiao Z; Diao W; Zhong C; Zhou J; Wu W
    Front Immunol; 2023; 14():1261290. PubMed ID: 38111580
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
    Huang F; Ruan Y; He X; Lian H; Yang J
    World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis.
    Waninger JJ; Ma VT; Chopra Z; Pearson AN; Green MD
    Cancer J; 2023 Sep-Oct 01; 29(5):279-284. PubMed ID: 37796646
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Audit of Sex and Gender Medicine Topics in Preclinical School of Medicine Curriculum.
    Trieglaff K; Zamzow MJ; Sutherland B; Farkas A; Pfister S
    WMJ; 2023 Sep; 122(4):243-249. PubMed ID: 37768763
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
    Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
    BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
    Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
    EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. breast cancer Incidence, Mortality, and Cost in Adolescent Idiopathic Scoliosis Patients and the Role of Low Dose Biplanar Radiography.
    Farivar D; Skaggs DL; Gabriel K; Illingworth KD
    J Am Acad Orthop Surg; 2023 Sep; 31(17):e633-e637. PubMed ID: 37432975
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
    Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
    J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of an early intervention with Hyperbaric Oxygen treatment on arm lymphedema and quality of life after breast cancer-an explorative clinical trial.
    Ammitzbøll G; Hyldegaard O; Forchhammer M; Rottensten H; Lanng C; Kroman N; Zerahn B; Jensen LT; Johansen C; Dalton SO
    Support Care Cancer; 2023 May; 31(5):313. PubMed ID: 37126076
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-breast02): a randomised, open-label, multicentre, phase 3 trial.
    André F; Hee Park Y; Kim SB; Takano T; Im SA; Borges G; Lima JP; Aksoy S; Gavila Gregori J; De Laurentiis M; Bianchini G; Roylance R; Miyoshi Y; Armstrong A; Sinha R; Ruiz Borrego M; Lim E; Ettl J; Yerushalmi R; Zagouri F; Duhoux FP; Fehm T; Gambhire D; Cathcart J; Wu C; Chu C; Egorov A; Krop I
    Lancet; 2023 May; 401(10390):1773-1785. PubMed ID: 37086745
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
    Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
    Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparing Outcomes in the Therapeutic and Prophylactic breast for Bilateral Mastectomy With Implant-Based breast Reconstruction.
    Peoples AE; Waler AR; Duet ML; Prabhu SS; Katz AJ
    Ann Plast Surg; 2023 Jun; 90(6S Suppl 4):S375-S378. PubMed ID: 36811478
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer.
    Wang L; Mi D; Hu J; Liu W; Zhang Y; Wang C; Chen Y; Chen C
    Cancer Lett; 2023 Feb; 555():216049. PubMed ID: 36608865
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
    Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
    JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Distance to radiation therapy facility influences surgery type among older women with early-stage breast cancer.
    Shrestha P; Chu QD; Hsieh MC; Yi Y; Peters ES; Trapido E; Yu Q; Ferguson T; Wu XC
    Cancer Med; 2023 Mar; 12(6):6842-6852. PubMed ID: 36495041
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
    Johnston SRD; Toi M; O'Shaughnessy J; Rastogi P; Campone M; Neven P; Huang CS; Huober J; Jaliffe GG; Cicin I; Tolaney SM; Goetz MP; Rugo HS; Senkus E; Testa L; Del Mastro L; Shimizu C; Wei R; Shahir A; Munoz M; San Antonio B; André V; Harbeck N; Martin M;
    Lancet Oncol; 2023 Jan; 24(1):77-90. PubMed ID: 36493792
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.